Skip to main content

Advertisement

Log in

Letter to “Pharmacotherapy in conjunction with diet and exercise program for the treatment of weight recidivism or weight loss plateau post-bariatric surgery: a retrospective review”

  • Letter to the Editor
  • Published:
Obesity Surgery Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Schwartz J, Suzo A, Wehr AM, et al. Pharmacotherapy in conjunction with diet an exercise program for the treatment of weight recidivism or weight loss plateau post-bariatric surgery: a retrospective review. Obes Surg. 2016;26:452–8.

    Article  PubMed  Google Scholar 

  2. Jester L, Wittgrove AC, Clark GW. Adjunctive use of appetite suppressant medications for improved weight management in bariatric surgical patients. Obes Surg. 1996;6:412–5.

    Article  PubMed  Google Scholar 

  3. Zoos I, Piec G, Horber EF. Impact of orlistat therapy on weight reduction in morbidly obese patients after implantation of the Swedish adjustable gastric band. Obes Surg. 2002;12(1):113–17.

    Article  Google Scholar 

  4. Zilberstein B, Pajecki D, de Brito Garcia AC, et al. Topiramate after adjustable gastric banding in patients with binge eating and difficulty in losing weight. Obes Surg. 2004;14(6):802–5.

    Article  PubMed  Google Scholar 

  5. Rothkopf MM, Bilof ML, Haverstick LP, et al. Synergistic weight loss and diabetes resolution with exenatide administration after laparoscopic gastric banding. Surg Obes Relat Dis. 2009;5(1):128–31.

    Article  PubMed  Google Scholar 

  6. Pajecki D, Halpern A, Cercato C, et al. Short term use of liraglutide in the management of patients with weight regain after bariatric surgery. Rev Col Bras Cir. 2012;40(3):191–5.

    Article  Google Scholar 

  7. Heber D, Greemway FL, Kaplan LM, et al. Endocrine and nutritional management of the post-bariatric surgery patient. An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95(11):4923–43.

    Article  Google Scholar 

  8. Pajecki D, Mancini MC, Halpern A, et al. Multidisciplinary approach of morbidly obese patients undergoing surgical treatment by adjustable gastric banding. Rev Col Bras Cir. 2010;37(5):328–32.

    PubMed  Google Scholar 

  9. Santo MA, Riccioppo D, Pajecki D et al. Weight regain after gastric bypass: influence of gut hormones. Obes Surg 2015 Oct 8.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Denis Pajecki.

Ethics declarations

Conflict of Interest

Dr Denis Pajecki and Dr Marco Aurelio Santo have no conflict of interest. Dr Marcio Correa Mancini is advisory board member of Novo Nordisk, Elli Lilly and Boehringer-Ingelheim.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed Consent

Does not apply.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pajecki, D., Santo, M.A. & Mancini, M.C. Letter to “Pharmacotherapy in conjunction with diet and exercise program for the treatment of weight recidivism or weight loss plateau post-bariatric surgery: a retrospective review”. OBES SURG 26, 1317–1318 (2016). https://doi.org/10.1007/s11695-016-2146-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-016-2146-8

Keywords

Navigation